 |
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, May 22, 2013
|
|
|
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, May 22, 2013
|
| Home | HealthTopics | Health Centers | Reference Library | Research |
 Join us on Facebook
|
Share on Facebook | Tweet |
|
Colon Cancer |
Erbitux and Irinotecan: High fever?06/08/2006 |
My father was diagnosed with colon cancer with liver metastasis a year and three months ago. He is currently taking Erbitux and Irinotecan (started 6 weeks ago) for stage IV cancer. His side effects include a persistent cough, runny nose, weakness, constipation, bloating, night sweats, and a high fever (as high as 102.2 at night) that seems to worsen with each treatment. A fairly recent blood test revealed no sign of infection. We are very worried about infection. (My dad has another blood test coming up.) What else can it possibly be?
There are many reasons why a patient with cancer can have a fever. It could be related to an infection, the cancer itself or the treatment itself. There are also other reasons that would be unlikely in this situation.
|
Tanios Bekaii-Saab, MD Assistant Professor of Medical Oncology Associate Professor of Pharmacology College of Medicine The Ohio State University |
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|